A new CT scan shows the tumor in an adult patient who recovered from a COIDS-19 vaccination.
The new scan, performed by Dr. Michael L. Gatton of the Johns Hopkins University School of Medicine, is the first of its kind in the United States.
“There is a good chance that it will help us determine the type of tumor and what it is,” Dr. Gannon said in a statement.
Gatton has been conducting scans for about two years to help determine the location and size of tumors.
“We have to make sure the patient is getting the right type of CT scan.
If there is no tumor, we have to get another scan to make a determination if there is any kind of tumor,” he said.
Gannon said the scan showed a tumor that was at least two centimeters in diameter, but the size of the tumor was not clear.
It could be a brain tumor, a blood clot, a tumor within the lung or it could be an enlarged spleen.
Dr. Gautam K. Kulkarni, director of the Brain and Spinal Surgery Department at Johns Hopkins Hospital, said in an email that the scan revealed that the tumor could be brain tumor.
Kulkarno said that, while there was no definitive indication that the patient had a brain cancer, it was possible that it was caused by a tumor inside the brain, such as a tumor from a chronic disease such as asthma.
“If this is confirmed to be a tumor, then we can safely say that we have identified the first case of brain tumor in a COID-19-vaccinated adult patient in the U.S.,” he said in the email.
The scans were part of an ongoing research effort by Gatton and his team to find out how much the brain tumor might be and how long it might remain.
In the current scan, the scan took place in a small, unincorporated part of the brain.
Dr. K.K. Kunkarni said it was important to have a smaller CT scan because it is not as easy to do in the operating room.
“So if you need to do it on a bigger CT, you have to do an incision in the skull and put a tube down through it.
It is very complicated,” he told Healthline.
The scan was performed to determine the size and location of the tumors.
The MRI showed no other changes in the MRI images of the patient, Dr. L.C.G. Kompany, the director of clinical studies for the MRI, told HealthLine.
“What was clear was the tumor, while it was growing, was not larger than it normally would be.
The tumor was in a different place and it was not growing in any particular direction,” he added.
The tumor was removed from the patient’s brain.
The next step in the research is to determine if it is still growing.
Dr K.M. Dharapak, a professor of neurology and neurosurgery at Columbia University Medical Center in New York City, said the CT scan may help researchers identify tumors that may cause symptoms in people who are at high risk of developing COIDS.
“I think it is exciting to think that the brain is an organ that is able to regenerate itself, so it could possibly be that there are tumor cells that can help regenerate that organ, and if there are some that are not cancerous, we can determine what the optimal tumor size is for that organ,” Dr Dharampak said.
Dr Gatton said in his statement that it is unclear what the future of the research will be.
“It may be that we will find that there is a tumor growing in the spinal cord, and then it will be possible to determine whether that tumor is cancerous or not,” he wrote.
Follow Elizabeth Palermo @techEpalermo.
Follow Live Science @livescience, Facebook & Google+.
Originally published on Healthline